<VariationArchive RecordType="classified" VariationID="9926" VariationName="NM_002637.4(PHKA1):c.695del (p.Ala232fs)" VariationType="Deletion" Accession="VCV000009926" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-06-23" MostRecentSubmission="2019-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24965" VariationID="9926">
      <GeneList>
        <Gene Symbol="PHKA1" FullName="phosphorylase kinase regulatory subunit alpha 1" GeneID="5255" HGNC_ID="HGNC:8925" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="72578814" stop="72714306" display_start="72578814" display_stop="72714306" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="71798663" stop="71934028" display_start="71798663" display_stop="71934028" Strand="-" />
          </Location>
          <OMIM>311870</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002637.4(PHKA1):c.695del (p.Ala232fs)</Name>
      <CanonicalSPDI>NC_000023.11:72667396:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="72667397" stop="72667397" display_start="72667397" display_stop="72667397" variantLength="1" positionVCF="72667396" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="71887247" stop="71887247" display_start="71887247" display_stop="71887247" variantLength="1" positionVCF="71887246" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>A232fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.71887247del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.71887247del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.72667397del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.72667397del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016599.2" sequenceAccession="NG_016599" sequenceVersion="2" change="g.51785del">
            <Expression>NG_016599.2:g.51785del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122670.2" sequenceAccession="NM_001122670" sequenceVersion="2" change="c.695del">
            <Expression>NM_001122670.2:c.695del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116142.1" sequenceAccession="NP_001116142" sequenceVersion="1" change="p.Ala232fs">
            <Expression>NP_001116142.1:p.Ala232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172436.2" sequenceAccession="NM_001172436" sequenceVersion="2" change="c.695del">
            <Expression>NM_001172436.2:c.695del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165907.1" sequenceAccession="NP_001165907" sequenceVersion="1" change="p.Ala232fs">
            <Expression>NP_001165907.1:p.Ala232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002637.4" sequenceAccession="NM_002637" sequenceVersion="4" change="c.695del" MANESelect="true">
            <Expression>NM_002637.4:c.695del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002628.2" sequenceAccession="NP_002628" sequenceVersion="2" change="p.Ala232fs">
            <Expression>NP_002628.2:p.Ala232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="311870.0004" DB="OMIM" />
        <XRef Type="rs" ID="1603266754" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002637.4(PHKA1):c.695del (p.Ala232fs) AND Glycogen storage disease IXd" Accession="RCV000010604" Version="5">
        <ClassifiedConditionList TraitSetID="2787">
          <ClassifiedCondition DB="MedGen" ID="C1845151">Glycogen storage disease IXd</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-01-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-06-23" MostRecentSubmission="2019-06-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15637709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22238410</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2787" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5203" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD IXd</ElementValue>
                <XRef Type="MIM" ID="300559" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXd</ElementValue>
                <XRef ID="Glycogen+storage+disease+IXd/8485" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010362" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD9D</ElementValue>
                <XRef Type="MIM" ID="300559" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3858" />
                <XRef ID="3858" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="715" DB="Orphanet" />
              <XRef ID="C1845151" DB="MedGen" />
              <XRef ID="MONDO:0010362" DB="MONDO" />
              <XRef Type="MIM" ID="300559" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30830" SubmissionDate="2019-06-20" DateLastUpdated="2019-06-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="311870.0004_GLYCOGEN STORAGE DISEASE, TYPE IXd" title="PHKA1, 1-BP DEL, 695C_GLYCOGEN STORAGE DISEASE, TYPE IXd" />
        <ClinVarAccession Accession="SCV000030830" DateUpdated="2019-06-23" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with muscle phosphorylase kinase deficiency (GSD9D; 300559) who had onset of symptoms at age 43 years, Wuyts et al. (2005) identified a 1-bp deletion, 695delC, in exon 7 of the PHKA1 gene, resulting in a frameshift and premature termination of the protein at amino acid position 242. The mutated protein was predicted to lack the multiphosphorylation domain located in the last 300 residues of the protein, thus rendering it nonfunctional.</Attribute>
              <Citation>
                <ID Source="PubMed">15637709</ID>
              </Citation>
              <XRef DB="OMIM" ID="300559" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Preisler et al. (2012) identified a 695delC mutation in a 69-year-old man with GSD IXd who had persistently raised levels of creatine kinase after treatment with statin therapy. He had worked in the military, and neurologic and EMG examination at age 64 were normal. Muscle biopsy showed increased glycogen and PHK activity was less than 11% of normal. Ischemic forearm exercise test was essentially similar to control, except for an increase in plasma ammonia. In contrast, aerobic exercise resulted in a blunted lactate response compared to controls, suggesting a mild impairment in muscle glycogenolysis. Preisler et al. (2012) suggested that high exercise intensity may activate myophosphorylase (PYGM; 608455) in patients with PHK deficiency, thus preserving some glycogenolysis in these patients.</Attribute>
              <Citation>
                <ID Source="PubMed">22238410</ID>
              </Citation>
              <XRef DB="OMIM" ID="608455" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKA1" />
          </GeneList>
          <Name>PHKA1, 1-BP DEL, 695C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 695C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="311870.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE, TYPE IXd</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30830" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE, TYPE IXd" MappingRef="Preferred">
        <MedGen CUI="C1845151" Name="Glycogen storage disease IXd" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

